Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
- DOI
- 10.1016/s1470-2045(23)00005-0
- Published
- 2023 Apr
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-23-00005-0,
title = {Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.},
author = {Rahman R and Polley MC and Alder L and Brastianos PK and Anders CK and Tawbi HA and Mehta M and Wen PY and Geyer S and de Groot J and Zadeh G and Piantadosi S and Galanis E and Khasraw M},
year = {2023},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(23)00005-0},
url = {https://doi.org/10.1016/s1470-2045(23)00005-0}
}RIS
TY - JOUR TI - Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference. AU - Rahman R AU - Polley MC AU - Alder L AU - Brastianos PK AU - Anders CK AU - Tawbi HA AU - Mehta M AU - Wen PY AU - Geyer S AU - de Groot J AU - Zadeh G AU - Piantadosi S AU - Galanis E AU - Khasraw M PY - 2023 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(23)00005-0 UR - https://doi.org/10.1016/s1470-2045(23)00005-0 ER -
APA
R, R., MC, P., L, A., PK, B., CK, A., HA, T., M, M., PY, W., S, G., J, D. G., G, Z., S, P., E, G., & M, K. (2023). Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(23)00005-0
Source records
- pubmed · retrieved 2026-09-27T09:30:11.831Z